Info@ThinkPinkRocks.com

Long-term histrelin implant shows promise for central precocious puberty

Long-term subcutaneous histrelin implant therapy is a viable option for patients with central precocious puberty who require continuous gonadotropin-releasing hormone analogue therapy, say researchers.

Continue Reading:
Long-term histrelin implant shows promise for central precocious puberty

Share

Leave a Reply